BARCLAYS PLC - LEGEND BIOTECH CORP ownership

LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 162 filers reported holding LEGEND BIOTECH CORP in Q3 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of LEGEND BIOTECH CORP
ValueSharesWeighting
Q3 2023$18,881
+226.6%
281,094
+235.7%
0.01%
+200.0%
Q2 2023$5,781
-46.4%
83,737
-62.5%
0.00%
-20.0%
Q1 2023$10,779
-57.1%
223,538
-55.6%
0.01%
-58.3%
Q4 2022$25,123
-99.8%
503,254
+67.1%
0.01%
-7.7%
Q3 2022$12,289,000
-23.7%
301,212
+2.8%
0.01%
+30.0%
Q2 2022$16,111,000
+80.7%
292,912
+19.4%
0.01%
+42.9%
Q1 2022$8,915,000245,3260.01%
Other shareholders
LEGEND BIOTECH CORP shareholders Q3 2022
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 814,586$56,230,87217.46%
Paradigm Biocapital Advisors LP 1,805,717$124,648,6459.63%
HHLR ADVISORS, LTD. 6,436,533$444,313,8739.46%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 1,123,692$77,568,4599.09%
RA Capital Management 6,264,707$432,452,7248.16%
Tri Locum Partners LP 116,768$8,060,4953.00%
Nicholas Investment Partners, LP 593,167$40,946,3182.80%
E Fund Management (Hong Kong) Co., Ltd. 51,679$3,5672.66%
Avidity Partners Management LP 798,900$55,148,0671.93%
Boxer Capital, LLC 600,000$41,4181.92%
View complete list of LEGEND BIOTECH CORP shareholders